https://www.selleckchem.com/pr....oducts/Rapamycin.htm
3%, P less then 0.05), higher rates of hospitalization (38.9% versus 21.3%, P less then 0.05), higher rates of undergoing a voiding cystourethrogram (19.4% versus 5.0%, P less then 0.05), and higher rates of UTI recurrence within 30 days (13.9% versus 4.7%, P less then 0.05). In multivariate analysis, recent hospitalization (odds ratio [OR] 4.3, confidence interval [CI] 1.2 to 16) and antibiotic therapy (OR 3.5, CI 1.5 to 8.5) within the previous 30 days were risk factors for resistant UTI. Conclusions Third-generation cephalosporin-r